# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-19-010124
Filing Date
2019-08-06
Accepted
2019-08-06 16:06:03
Documents
9
Period of Report
2019-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | auph-0630196xk.htm | 6-K | 17947
2 | EXHIBIT 99.2 | exhibit991-20190630interim.htm | EX-99.2 | 688236
3 | EXHIBIT 99.3 | exhibit992-20190630mda.htm | EX-99.3 | 378488
4 | EXHIBIT 99.4 | exhibit993-20190630certifi.htm | EX-99.4 | 15994
5 | EXHIBIT 99.5 | exhibit994-20190630certifi.htm | EX-99.5 | 15740
6 |  | aurinialogoweb700pxa06.jpg | GRAPHIC | 77311
7 |  | auroralogoa01.jpg | GRAPHIC | 12814
8 |  | consolidatedfinancialstate01.jpg | GRAPHIC | 233177
9 |  | consolidatedfinancialstate02.jpg | GRAPHIC | 233177
| Complete submission text file | 0001628280-19-010124.txt |  | 1873162

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 191002081
SIC: 2834 Pharmaceutical Preparations